Skip to main content
Clinical Trials/KCT0002169
KCT0002169
Recruiting
未知

Optimal Treatment Strategy Based on Prognostic Groups for Pediatric de Novo Acute Myeloid Leukemia

ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
The Catholic University of Korea, Seoul St. Mary's Hospital
Enrollment
350
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients who were newly diagnosed with de novo AML
  • 2\) Patients who had recurrent cytogenetic abnormalities of AML even though the bone marrow blast percent is lower than 20%

Exclusion Criteria

  • 1\) Acute promyelocytic leukemia
  • 2\) Down syndrome AML
  • 3\) Therapy\-related AML
  • 4\) AML developed from myelodysplastic syndrome or other marrow failure syndrome
  • 5\) Isolated myeloid sarcoma without bone marrow involvement
  • 6\) Patients who cannot undergo chemotherapy as scheduled due to serious complications at diagnosis

Outcomes

Primary Outcomes

Not specified

Similar Trials